Loading...
Cookies & Privacy. This website uses cookies to ensure you get the best experience on our website.

What is a Synthetic Hybrid-Scale Fiber Matrix?

Acera Surgical has engineered a new class of resorbable synthetic hybrid-scale fiber matrices designed to restore damaged tissue.

jc_gellidon_UIp163xCV6w_unsplash_square.jpg

Acera's patented technology enables the engineering of matrices which closely resemble the architecture of native tissue. The hybrid-scale fiber products developed with this technology have been shown to deliver patient healing without the limitations of traditional biologics.

Hybrid-scale fiber matrices are engineered from electrospun fibers ranging in fiber diameter (from a few nanometers to a few microns) to create a fully resorbable healing scaffold. Native cells rapidly infiltrate the scaffold, and then proliferate and differentiate to form new granulation tissue.

Gradual and defined resorption of a hybrid-scale fiber matrix is designed to occur at a similar rate to cellular ingrowth and new tissue formation of the surrounding native tissue. As the scaffold resorbs, the porosity of the matrix gradually increases to support continued tissue integration and neovascularization, while eliciting a minimal inflammatory response.

Synthetic hybrid-scale fiber matrices are easy to handle and apply in the clinical setting. The soft and flexible material easily conforms to the wound site, yet is strong enough to manipulate and suture as needed.

I believe that hybrid-scale fiber technology has the potential to really change the way that clinicians approach wound healing.

- Matthew MacEwan, PhD, CSO

While researchers have studied the potential of electrospun fibers for many years, Acera's technology platform has enabled their practical application for patient healing.

Hybrid-scale fiber matrices are completely synthetic and do not elicit excessive inflammation, a complaint of traditional treatments. The fully synthetic raw materials used to fabricate our products are also ideal for patients who raise ethical or religious objections to traditional biologics. 

With our patented technology, Acera Surgical has engineered a revolution in healing.

Acera Surgical’s products and/or services may be covered by or for use under one or more of U.S. Patent Nos. 10,080,687, 10,124,089, 10,149,749, 10,441,403, 10,441,685, 10,588,734, 10,617,512, 10,632,228, 10,682,444, 10,888,409, and/or one or more patents in Australia, Canada, Europe, Japan, Korea, Singapore, and/or in other jurisdictions, as well as other patents that are pending.  For additional information, please contact information@acera-surgical.com.

Contact a surgical account executive today!

Contact us today to learn more or request a product demonstration.
Revolutionizing Healing. Changing Lives.
  •  
Cerafix®, Covora®, and Restrata® are registered trademarks of Acera Surgical Inc.
  •